Zai Lab Limited ZLAB

NAS: ZLAB | ISIN: US98887Q1040 26/04/2024

15,91 USD (+1,08%)

(+1,08%) 26/04/2024

Grafiek Zai Lab Limited

Grafiek Zai Lab Limited

1 dag1d 1,08%
1 week1w 6,14%
1 maand1m -4,84%
3 maanden3m -29,97%
6 maanden6m -37,34%
1 jaar1j -54,27%
5 jaar5j -42,19%

woensdag 8 mei 2024, 22:00

Kwartaalcijfers (1ste kwartaal)

Zai Lab Limited in het nieuws

Toon enkel gratis nieuws

25 juli 2022 · Qiming's Portfolio Company InventisBio Lists on STAR Market · Persbericht

11 juli 2022 · Qiming Venture Partners Announces Closing of Funds Totaling US$3.2 Billion · Persbericht

13 april 2022 · Qiming's Nisa Leung, Duane Kuang Named on 2022 Forbes Midas List · Persbericht

9 november 2021 · Blueprint Medicines and Zai Lab Announce Strategic Collaboration and License Agreement for BLU-945 and BLU-701 in Greater China · Persbericht

25 augustus 2021 · Zhongchao Inc. Expands Patient Management Business to Ovarian Cancer Market · Persbericht

1 juni 2021 · Mirati Therapeutics and Zai Lab Enter Into a Collaboration to Develop and Commercialize Adagrasib in Greater China · Persbericht

18 februari 2021 · Zai Lab to Announce Full-Year 2020 Financial Results on March 1, 2021 · Persbericht

28 januari 2021 · Zai Lab Announces Upcoming Presentations in February Investor Conferences · Persbericht

11 januari 2021 · Turning Point and Zai Lab Broaden Collaboration · Persbericht

6 januari 2021 · argenx and Zai Lab Announce Strategic Collaboration for Efgartigimod in Greater China · Persbericht

Profiel Zai Lab Limited

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Werknemers: 258

Aandelen Zai Lab Limited

Beurswaarde: 1,58 miljard USD

Effecten: 99,21 miljoen

Beta: 1,71

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe